ATC Group: M03AB01 Suxamethonium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M03AB01 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M03 Muscle relaxants
3 M03A Muscle relaxants, peripherally acting agents
4 M03AB Choline derivatives
5 M03AB01 Suxamethonium

Active ingredients in M03AB01

Active Ingredient

Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle.

Related product monographs

Document Type Information Source  
 ANECTINE Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 ETHICHOLINE Solution for injection MPI, US: SPL/PLR Marketing Authorisation Holder
 QUELICIN Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Canada (CA)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Malta (MT)

Romania (RO)

Singapore (SG)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.